Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis
Hongjuan You, Dongchen Yuan, Qi Li, et al.
International Journal of Biological Macromolecules (2022) Vol. 226, pp. 996-1009
Closed Access | Times Cited: 10

Showing 10 citing articles:

Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
Anja Schollmeier, Mirco Glitscher, Eberhard Hildt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4964-4964
Open Access | Times Cited: 34
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis
Riccardo Nevola, Domenico Beccia, Valerio Rosato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7651-7651
Open Access | Times Cited: 17
Ubiquitin: A double-edged sword in hepatitis B virus-induced hepatocellular carcinoma
Arpita Kar, Sandipan Mukherjee, Soumyadeep Mukherjee, et al.
Virology (2024) Vol. 599, pp. 110199-110199
Closed Access | Times Cited: 4
METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1
Rui Yang, Cheng Yang, Danjie Su, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 4, pp. 562-573
Open Access | Times Cited: 3
Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis
Hongjuan You, Qi Li, Lihong Ma, et al.
Journal of Molecular Cell Biology (2024) Vol. 16, Iss. 4
Open Access | Times Cited: 3
SIAH2 suppresses c‐JUN pathway by promoting the polyubiquitination and degradation of HBx in hepatocellular carcinoma
Qinghe Hu, Zhiyi Liu, Yao Liu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 3
Abnormal protein SUMOylation in liver disease: novel target for therapy
Yanfang Yang, Fuxun Yu
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 719-731
Closed Access | Times Cited: 2
Distinctive tumorigenic significance and innovative oncology targets of SUMOylation
Heng Zhou, Na Deng, Yanshu Li, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3127-3149
Open Access | Times Cited: 2
Targeted inhibition of SUMOylation: treatment of tumors
Hongwei Zhao, Panpan Zhao, Chao Huang
Human Cell (2024)
Closed Access | Times Cited: 1
Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis
Hongjuan You, Lihong Ma, Xing Wang, et al.
Cellular Oncology (2023) Vol. 47, Iss. 2, pp. 639-655
Closed Access | Times Cited: 3
Nuclear pore complex protein RANBP2 and related SUMOylation in solid malignancies
Xinning Yu, Huatao Wu, Zhenhua Wu, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101407-101407
Open Access
Page 1

Scroll to top